文献

J-GLOBAL ID：201602264225526422   整理番号：16A1370113

CHA₂DS₂-VAScスコアが1以下で抗凝固療法を受けていない肥大型心筋症,非弁膜症性心房細動の患者における,虚血性脳卒中と全身性塞栓症の発生率

Incidence of ischemic stroke and systemic embolism in patients with hypertrophic cardiomyopathy, nonvalvular atrial fibrillation, CHA2DS2-VASc score of ≦1 and without anticoagulant therapy

著者 (8件)： Yang Yin-Jian (Chinese Academy of Medical Sciences and Peking Union Medical College) ,  Yuan Jin-Qing (Chinese Academy of Medical Sciences and Peking Union Medical College) ,  Fan Chao-Mei (Chinese Academy of Medical Sciences and Peking Union Medical College) ,  Pu Jie-Lin (Chinese Academy of Medical Sciences and Peking Union Medical College) ,  Fang Pi-Hua (Chinese Academy of Medical Sciences and Peking Union Medical College) ,  Ma Jian (Chinese Academy of Medical Sciences and Peking Union Medical College) ,  Guo Xi-Ying (Chinese Academy of Medical Sciences and Peking Union Medical College) ,  Li Yi-Shi (Chinese Academy of Medical Sciences and Peking Union Medical College)
資料名： Heart and Vessels  (Heart and Vessels)
巻： 31  号： 7  ページ： 1148-1153  発行年： 2016年07月 
JST資料番号： X0101A  ISSN： 0910-8327  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： ドイツ (DEU)  言語： 英語 (EN)

抄録/ポイント： 非弁膜症性心房細動(NVAF),CHA<sub>2</sub...

シソーラス用語： ヒト ,...
準シソーラス用語： *虚血性脳卒中 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=16A1370113&from=J-GLOBAL&jstjournalNo=X0101A") }}

著者キーワード (5件)： Hypertrophic cardiomyopathy ,  Atrial fibrillation ,  CHA2DS2-VASc score ,  Ischemic stroke ,  Systemic embolism

分類 (2件)： 循環系の疾患  (GJ03000C) ,  神経系の疾患  (GN03000O)

引用文献 (27件)：

• January CT, Wann LS, Alpert JS, Calkins H, Cleveland JJ, Cigarroa JE, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW (2014) 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 64:e1-e76
• Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H, McKenna WJ, Mogensen J, Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C, Rutten FH, Tillmanns C, Watkins H (2014) 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 35:2733-2779
• Rakowski H, Sasson Z, Wigle ED (1988) Echocardiographic and Doppler assessment of hypertrophic cardiomyopathy. J Am Soc Echocardiogr 1:31-47
• Hohnloser SH, Pajitnev D, Pogue J, Healey JS, Pfeffer MA, Yusuf S, Connolly SJ (2007) Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy. J Am Coll Cardiol 50:2156-2161
• Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137:263-272

タイトルに関連する用語 (8件)： スコア ,  抗凝固療法 ,  肥大型心筋症 ,  非弁膜症性心房細動 ,  患者 ,  虚血性脳卒中 ,  全身性塞栓症 ,  発生率